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Introduction. Porphyromonas gingivalis is considered as a major etiological agent in the onset 
and progression of chronic destructive periodontitis. Porphyromonus gingivalis fimA type has been 
correlated to the virulence potential of the strain; therefore this gene could be involved in the ability 
of P. gingivalis to reach blood stream.
Objective. The classifications of P. gingivalis fimA types will be compared in subgingival plaque 
and blood samples collected after scaling and root root planing of periodontitis patients.
Materials and methods. Fifteen periodontitis patients requiring scaling and root planing were 
enrolled. P. gingivalis isolates were classed to genotype with fimA type-specific PCR assay. fimA 
gene was sequenced if the isolate was listed as unclassifiable after PCR technique.
Results. Six patients showed positive P. gingivalis bacteremia. The most frequent fimA was fimA 
type II, followed by Ib, III and IV. In blood strains, type II was followed by IV, Ib and III. 
Conclusion. Type II was the most frequent genotype in blood samples and in subgingival plaque 
samples. However, no correlation was found between the frequency of any fimA type with SRP 
induced bacteremia. P. gingivalis fimA type appears to be conserved within individual patients 
throughout the times of sample collection. fimA gene sequence results were not in agreement with 
results of fimA genotyping by PCR.
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Distribución de los genotipos de fimA en cepas de Porphyromonas gingivalis aisladas de 
placas subgingivales y de sangre durante bacteriemias
Introducción. Porphyromonas gingivalis es el principal agente etiológico de la periodontitis. El 
gen fimA ha sido relacionado con la virulencia del microorganismo, lo cual sugiere la participación 
de dicho gen en la capacidad del microorganismo para alcanzar el torrente sanguíneo. 
Objetivo. Estudiar la distribución de los tipos de fimA de P. gingivalis en muestras de placa 
subgingival y de sangre obtenidas durante bacteriemias después de raspaje y alisado radicular. 
Materiales y métodos. Se practicó un alisado radicular a 15 pacientes con periodontitis. Se 
obtuvieron aislamientos clínicos de P. gingivalis de la placa subgingival y durante la bacteriemia 
inducida por el procedimiento. Para la genotipificación se utilizó la técnica de reacción en cadena 
de la polimerasa (PCR) específica para fimA. En los aislamientos no clasificables por PCR se 
realizó secuenciación del gen fimA.
Resultados. Seis pacientes fueron positivos para bacteriemia por P. gingivalis. La distribución de 
fimA evaluada en 30 aislamientos de placa subgingival y de sangre mostró una mayor frecuencia 
del fimA tipo II de P. gingivalis. En los aislamientos de placa subgingival, la detección de fimA 
tipo II fue seguida por Ib, III y IV; sin embargo, en los aislamientos de sangre el tipo II fue seguido 
por los tipos IV, Ib y III.
Conclusión. En los aislamientos de sangre y de placa subgingival de pacientes con periodontitis 
el fimA más frecuente fue el tipo II; no fue posible correlacionar el tipo de fimA con la bacteriemia 
inducida por el alisado radicular. Los resultados de la secuenciación del gen fimA no concuerdan 
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Periodontal disease (gingivitis and periodontitis) 
represents a group of infections caused by 
microorganisms that colonize, modify, penetrate 
and invade periodontal tissue, destroying 
connective tissue attachment and alveolar 
bone, and ultimately leading to tooth loss. 
Periodontitis has been reported as a public 
health problem, with approximately 15% of 
the population suffering from the most severe 
form (1). Porphyromonas gingivalis is a Gram 
negative, anaerobic, black pigmented rod. It is an 
opportunistic periodontal pathogen, and, although 
it may be absent or decreased in healthy sites, it 
becomes increased in prevalence and proportion 
in actively degrading periodontal pockets. 
Consequently, it has been described as a major 
etiological agent in the onset and progression of 
chronic destructive periodontitis. Porphyromonas. 
gingivalis possesses several virulence factors: 
fimbriae, hemagglutinins, haemolysin, LPS, 
proteases, outer membrane vesicles, capsular 
antigens and ceramides. All these factors 
are important to fulfill nutritional and growth 
requirements of P. gingivalis and its virulence 
potential is likely to be an orchestration among 
all these components. Fimbriae are filamentous 
peritrichous structures located on the surface 
of the bacterium and described as one of the 
most important virulence factors of P. gingivalis 
because of their immunological and biological 
activities (2). Fimbriae are involved in most 
adherence properties exhibited by P. gingivalis, 
i.e., the interaction with salivary molecules, oral 
epithelial cells and other oral bacteria, as well as 
in the induction of cytokines secretion of infected 
cells (3-5). The major fimbriae subunit, fimbrillin 
(FimA), ranges from 41 to 49 kDa (6) and is 
encoded by the fimA gene. Six variants (I-V and 
Ib) of the fimA gene have been described based 
on nucleotide sequences from reference strains 
and dental plaque samples isolated from patients 
with or without periodontal disease. Indeed, fimA 
genotyping may prove useful to identify fimA 
types involved in adult periodontitis development 
and to assess risk and assist treatment planning 
of periodontal disease (7,8).
Several reports have suggested the relationship 
between periodontal disease and systemic 
complications (9), such as cardiovascular disease, 
stroke, lung inflammation and preterm low weight 
birth (10-13). Periodontal disease can be involved 
in systemic diseases if periodontopathic bacteria 
become present in the bloodstream, then 
leading to extraoral infections. Bacteria associated 
with transient oral bacteremia can reach the 
bloodstream  after specific dental procedures, 
chewing, tooth brush or dental flossing (14-
17). Once periodontopathic bacteria reach the 
bloodstream, their virulence can modify host cell 
functions, inducing the expression of several 
chronic inflammatory factors, and interfering with 
regulation of the local inflammatory reaction (18).
The aim of the current study was to determine 
the distribution of P. gingivalis fimA type in 
subgingival plaque samples and blood samples 
collected after scaling and root planing (SRP)-
induced transient bacteremia.
Material and methods
Subjects and sample collection
Population. Fifteen unrelated, systemically 
healthy adults were included in this study. They 
were selected from subjects who attended the 
Graduate Clinic of Periodontics and Oral Medicine 
Service of Universidad El Bosque in Bogotá, 
Colombia. All subjects were diagnosed with either 
GCP (generalized chronic periodontitis) or GAP 
(generalized aggressive periodontitis). Patients 
must have had at least 10 pockets with probing 
depth ≥7 mm requiring periodontal surgery after 
scaling and root planing. All patients were positive 
for P. gingivalis in subgingival plaque sample 
before the SRP (scaling and root planning). In 
addition, laboratory exams, such as a glucose 
test and haemogram, were made in order to 
Biomédica 2009;29:298-306Pérez-Chaparro PJ, Lafaurie GI, Gracieux P, et al.
300
Table 1. Primer sets for 16S rRNA, fimA genotyping, and fimA gene sequencing.
Primer Sequence Product length (bp)
fimA type IF CTG TGT GTT TAT GGC AAA CTT C 392
fimA type IR AAC CCC GCT CCC TGT ATT CCG A 
fimA type IbF CAG CAG AGC CAA AAA CAA TCG 271
fimA type IbR TGT CAG ATA ATT AGC GTC TGC  
fimA type IIF ACA ACT ATA CTT ATG ACA ATG G 257
fimA type IIR AAC CCC GCT CCC TGT ATT CCG A 
fimA type IIIF ATT ACA CCT ACA CAG GTG AGG C 247
fimA type IIIR AAC CCC GCT CCC TGT ATT CCG A  
fimA type IVF CTA TTC AGG TGC TAT TAC CCA  A  251
fimA type IVR AAC CCC GCT CCC TGT ATT CCG A  
fimA type VF AAC AAC AGT CTC CTT GAC AGT G 462
fimA type VR TAT TGG GGG TCG AAC GTT ACT GTC 
P.gingivalis16S rRNA F AGG CAG CTT GCC ATA CTG CG 404
P.gingivalis 16S rRNA R ACT GTT AGC AAC TAC CGA TGT 
M1 GCG CGA ATT CGC GCA GCA AGG
  CCA GCC CGG AGC ACA ACAC 1044 to 1083
M2 CGC GGA ATT CGA GCG AAC CCC 
  GCT CCC TGT ATT CCG ATA 
deselect patients with medical compromise. 
The Ethics Committee of Universidad El Bosque 
approved the current study, and all patients 
provided informed consent. All patients were 
diagnosed according to criteria established by 
the American Association of Periodontics (AAP) 
in 1999 (19). Clinical history was evaluated and 
radiographic examinations were performed for 
each patient. Periodontal examination included 
the assessment of pocket depth, loss of 
attachment and bleeding. The exclusion criteria 
for were applied as described previously (17).
Samples collection. Samples were collected 
from subgingival plaque and from blood (17). A 
subgingival study inclusion sample was collected 
from 6 pockets (>7 mm). On the surgical day, a 
second subgingival sample was collected prior to 
scaling and root planning procedure. The delay 
between the two samples was one to four weeks. 
Four blood samples were collected from the 
antecubital vein at the following time points: (H1) 
prior to the scaling and root planning procedure; 
(H2) immediately at the end of the procedure; 
(H3) 15 minutes and (H4) 30 minutes after the 
end of the procedure. SRP was assessed during 
10 minutes (10 sites, 1 minute per site) (20).
Porphyromonas gingivalis growth conditions 
and identification. P. gingivalis was cultured 
on enriched Brucella agar (BBL Microbiology 
Systems, Cockeysville, Md, USA.) for 6 days. 
Colony morphology, CAAM (carbobenzoxy-L-
arginin-7-amino-4-metylcou-marin, Sigma, St. 
Louis, Mo, USA) positivity, the commercially 
available rapid-ID 32A system (Biomerieux), 
and 16S rRNA based PCR (polymerase chain 
reaction) using primers described by Ashimoto 
et al. (21) (Table 1) were performed to identify 
and confirm P. gingivalis.  
Identification of fimA genotypes by PCR. The 
six primer sets used were based on the primer 
design described by Amano et al. (22,23) and 
Nakagawa et al. (8,24) (Table 1). Porphyromonas 
gingivalis strains ATCC33277 (fimA type I), 
OMZ409 (provided by Pr Gmür, Zurich; fimA 
type II), TN (fimA type III), ML2G (fimA type Ib), 
and W83 (fimA type IV) were used as positive 
controls. For DNA samples, six-day-old bacterial 
colonies were added to sterile MiliQ water and 
boiled. PCR was performed in a final volume 
of 25 μl containing 10mM dNTPmix, 0.8 μM of 
each primer, 2mM of MgCl2, 1X of Taq Buffer 
and 1.25 U of Taq Polymerase Go taq Flexi DNA 
Polymerase (Promega); 5 μl of the bacterial DNA 
suspension was added to the PCR reaction, and 
the final volume was adjusted with sterile MiliQ 
water. Final concentration of MgCl2 for fimA 
type II PCR was decreased to 1mM. PCR was 
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performed as follows: an initial denaturation 
cycle of 95°C for 5 min, 30 cycles of 94°C for 
30 s, 58°C for 30 s, 72°C for 30s, and a final 
extension cycle at 72°C for 7 min, according to 
previously described methods by Amano et al. 
(22, 23). Samples showing positive amplification 
for fimA type I and fimA type II were processed 
for fimA type Ib. When fimA type Ib amplification 
was positive, RsaI restriction was performed. 
Samples showing positive restrictions were 
classified as fimA type Ib (25). PCR products 
were resolved by electrophoresis via a 2% 
agarose Seakem LE gel (Cambrex).
fimA sequencing. For unclassifiable strains, 
whole fimA gene amplification was undertaken 
using the universal primer set M1 and M2 (Table 
1) and amplifying conditions previously described 
by Fujiwara et al. (26). The PCR products were 
purified using the Qiaquick PCR purification kit 
(Qiagen) following manufacturer instructions. 
The PCR sequencing of the fimA gene was 
performed with primers M1 and M2 with the 
BigDye® Terminator v3.1 Cycle Sequencing Kits 
following manufacturer instructions. The results 
were analyzed by an ABI PRISM 3100 Genetic 
Analyzer (Applied Biosystems).
Nucleotide sequence analysis. Sequences 
obtained from each isolate were edited and 
assembled using the ContigExpress tool of the 
Vector NTI Advance 10 program (Invitrogen). 
The ClustalW2 multiple sequence alignment 
program (http://www.ebi.ac.uk/Tools/clustawl2/
index.htm) was used to compare similarity 
between the nucleotide sequence of the fimA 
gene from clinical strain and the nucleotide 
sequences from reference strains for fimA 
type I (Genbank accession no. D17795 (strain 
33277)), type II (Genbank accession no.D17799 
(strain OMZ409)), type III (Genbank accession 
no. D17801 (strain BH6/26)), type IV (Genbank 
accession no. AE015924 (strainW83)), type 
V (Genbank accession no. AB027294 (strain 
HNA-99)), and type Ib (Genbank accession 
no. AB058848 (strain HG1691). In addition, 
phylogenetic trees were constructed based 
on the unweighted pair group method with 
arithmetic mean (UPGMA) analysis to represent 
relationship between DNA sequences by 
comparisons based on sequence homology. 
For the multiple alignment and phylogram 
construction, the start codon for all the strains 
was considered to be 5’-ATG-3’(98pb) and the 
stop codon 5’-TAA-3’(1247pb). The start codon 
was previously described by Xie et al. (27).
Results
Subjects and P. gingivalis strain 
classification
Fifteen patients were positively identified for P. 
gingivalis strains. Nine patients were diagnosed 
with GCP and 6 with GAP. Independent of the 
diagnosis, patients were divided in two groups. 
Group 1 (6 patients) were P. gingivalis-positive 
in samples from oral cavity (subgingival plaque) 
and bloodstream (positive bacteremia) (Table 2). 
The number of P. gingivalis collected in blood was 
higher 15 minutes after the end of the procedure 
(4/7) followed by those collected just after the 
end of the procedure (2/7) and 30 minutes 
after the end of the procedure (1/7). Group 2 (9 
patients) were positive only in subgingival plaque 
samples (negative bacteremia). Several strains 
from to each group were lost due to inadequate 
cryopreservation and marked as “not able to 
process” (NA) (Table 2).
fimA genotypes by PCR
The results of fimA genotype identification from 
P. gingivalis clinical collection are summarized 
in Table 3. Genotype assignment was made 
as follows: strains were classified as a given 
fimA type when the expected PCR length was 
produced for one of the fimA types. From a total 
of 30 P. gingivalis clinical isolates, two were 
classified as being fimA type I, five as fimA type 
Ib, fourteen as fimA type II, and two as fimA type 
III. Strains were listed as unclassifiable when 
they were positive for more than one fimA type 
primer sets, as well as after being subjected 
to whole fimA gene sequencing. Seven strains 
were unclassifiable (Table 3).
fimA sequencing analysis
Single nucleotide sequences of the entire 
fimA gene were obtained from 7 strains listed 
previously as unclassifiable (UIBO 655, UIBO 655 
H3, UIBO 655 H4, UIBO 695, UIBO 472, UIBO 
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Table 2. Subjects, Porphyromonas gingivalis identification and classification.
     P. gingivalis isolates
Patient Diagnosis1 In subgingival plaque sample In blood sample2
 Inclusion study  Before scaling H1 H2 H3 H4
 sample and root planing
 Group 1: patients with P. gingivalis positive bacteremia
1 GCP NA 3 UIBO 655   UIBO 655 H3 UIBO 655 H4
2 GAP NA UIBO 695  UIBO 695 H2  
3 GCP NA UIBO 728   UIBO 728 H3 
4 GAP UIBO 735 UIBO 771  UIBO 771 H2  
5 GAP UIBO 751 UIBO 801   UIBO 801 H3 
6 GCP NA UIBO 1047   UIBO 1047 H3 
 Group 2: patients without P. gingivalis bacteremia
  NA
7 GCP  UIBO 482    
8 GCP NA UIBO 472    
9 GAP NA UIBO 710    
10 GCP UIBO 456  UIBO 465    
11 GAP UIBO 712 UIBO 742    
12 GCP UIBO 507 UIBO 537    
13 GAP UIBO 724 UIBO 760    
14 GCP UIBO 741 UIBO 783    
15 GCP UIBO 392 UIBO 421    
1  GCP: adult generalized chronic periodontitis, GAP: generalized aggressive periodontitis
2  Blood samples were collected before scaling and root planing procedure (H1), just after the end of scaling and root planing  
 procedure (H2), 15 minutes after the end of scaling and root planing procedure (H3), 30 minutes after the end of   
 scaling and root planing procedure (H4).
3  NA: Not able to process the sample
742 and UIBO 537). After multiple alignment 
and phylogenetic tree analysis between the 
nucleotide sequences of the clinical strains and 
the sequences of the reference strains for the 
six fimA types (Figure 1), one fimA type was 
assigned to each strain. Results are summarized 
in Table 3. As a whole, isolates UIBO 655, UIBO 
655 H3 and UIBO 537 positive for specific primer 
sets fimA type II and IV PCR were assigned to 
fimA type IV cluster. Isolate UIBO 655 H4 was 
positive for specific primer sets fimA type I, II 
and IV PCR and was assigned to fimA type IV 
cluster. Strains UIBO 695 and UIBO 742 were 
positive for specific primer sets fimA type I, II and 
IV PCR and were assigned to fimA type II cluster. 
Strain UIBO 472 was positive for specific primer 
set fimA type I, and II PCR and was assigned to 
fimA type III cluster.
Frequency of fimA genotypes
The esults from fimA genotyping by PCR and 
nucleotide sequence analysis of fimA whole 
gene can be summarized as follows: three were 
classified as being fimA type II, two as fimA type 
IV, one as fimA type Ib, one as fimA type III. All 
P. gingivalis strains found in the bloodstream 
showed the same fimA type as the isolate from 
the same day SRP in patients 1-6 (Table 3, 4). 
In group 2 (negative bacteremia) fimA type 
identifications of P. gingivalis were as follows: 
eight strains were fimA type II, three were fimA 
type Ib, two were fimA type I, one was fimA 
type III and one was fimA type IV. In samples 
collected from one patient, the fimA genotypes 
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Table 3. fimA profiles of Porphyromonas gingivalis strains by PCR technique.
 In subgingival In blood
  plaque sample sample fimA type fimA type specific PCR assay
Patients Inclusion Before scaling I Ib II III IV V  Assigned 
 study and root       fimA type 
 sample planing       after  
         sequencing
Group 1
1  NA UIBO 655  Unclassifiable - NI + - + - IV
    UIBO 655 H3 Unclassifiable - NI + - + - IV
    UIBO 655 H4 Unclassifiable + - + - + - IV
2  NA UIBO 695  Unclassifiable 300pb NI + - + - II
    UIBO 695 H2 II  300pb NI + - - - NS
3  NA UIBO 728  III  - - - + - - NS
    UIBO 728 H3 III  - - - + - - NS
4  UIBO 735   II  300pb NI + - - - NS
   UIBO 771  II  300pb NI + - - - NS
    UIBO 771 H2 II  300pb NI + - - - NS
5  UIBO 751   II  300pb NI + - - - NS
   UIBO 801  II  300pb NI + - - - NS
    UIBO 801 H3 II  300pb NI + - - - NS
6  NA UIBO 1047  Ib  + + + - - - NS
    UIBO 1047 H3 Ib  + + + - - - NS
Group 2             NS
7  NA UIBO 482  Ib  + + + - - - NS
8  NA UIBO 472  Unclassifiable + - + - - - III 
9  NA UIBO 710  II  300pb NI + - - - NS
10 UIBO 456   Ib  + + + - - - NS
   UIBO 465  Ib  + + + - - - NS
11 UIBO 712   II  - NI + - - - NS
   UIBO 742  Unclassifiable - NI + - + - II 
12 UIBO 507   II  300bp NI + - - - NS
   UIBO 537  Unclassifiable - NI + - + - IV 
13 UIBO 724   I  + NI - - - - NS
   UIBO 760  I  + NI - - - - NS
14 UIBO 741   II  300bp NI + - - - NS
   UIBO 783  II  - NI + - - - NS
15 UIBO 392   II  300bp NI + - - - NS
   UIBO 421  II -  NI + - - - NS
              NS
(+) positive PCR amplification; (–) negative PCR amplification; NI: PCR primer set not indicated. Samples showing positive 
amplification for fimA type I and fimA type II were processed for fimA type Ib. NS: Not sequenced. NA: Non ability of process 
of the sample 
Figure 1. Phylogenetical tree of Porphyromonas gingvalis isolates and fimA reference strain.
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Analysis summarizing fimA identifications in the 
study population and the relationship between 
fimA type and periodontal diagnostics are listed 
in Table 4. Results reveal the high frequency of 
fimA type II in the total of the strains (17/30), in 
the total of patients (9/15) and especially in those 
diagnosed with GAP (5/15).
Discussion
Classification of fimA genotypes identified in 
strains of Colombian periodontitis patients 
shows that type II is the most frequent type, as is 
consistent with Amano et al. (22,23), Nakagawa 
et al. (8), Missailidis et al. (25) and Eick et al. 
(28).Those results were obtained in large (73 
patients, (23)) and small samples (15 patients, 
(28)) of periodontitis patients. The second most 
frequent type in the current study was type 
Ib. This again was in agreement with the fimA 
Ib distribution in periodontitis patients in the 
Brazilian population described by Missailidis et 
al. (25) and in an Asian population described by 
Nakagawa et al. (8) where type Ib was strongly 
associated with periodontitis disease. Type I, III 
and IV were detected less frequently, similar to 
the occurrence rate in periodontitis patients in 
the Brazilian population (25), where fimA type I, 
III and IV showed a similar frequency, although 
less frequently detected than fimA type II and 
Ib. Type V was not detected in the Colombian 
population. The absence of fimA type V was 
probably because type V is detected mainly in 
the healthy population (22). Moreover, type V 
was absent in gingivitis and periodontitis patients 
(25). Concerning the relation between fimA 
type and periodontitis aggression, fimA type II 
may exhibit an increased pathogenic potential, 
because it was the most frequent type among 
GAP patients. These findings are in agreement 
with previous studies that have shown that fimA 
type II, IV and Ib strains exhibit a more virulent 
potential, while fimA type I, III and V are referred 
as less virulent or avirulent (8,22,24,25,29).
fimA type identifications of P. gingivalis isolated 
from blood samples collected after orally induced 
bacteremia by SRP procedures showed a wide 
heterogeneity (type II 3/7, type IV 2/7, type Ib1/7, 
type III 1/7). This heterogeneity enabled us to 
associate a particular fimA type with the ability of 
the bacteria to reach bloodstream.
In both groups, genotyping data of isolates within 
individual patients showed the same fimA type. 
This finding indicated that the fimA genotype 
was conserved during the sample period of the 
study and also that one fimA type was unique to 
a single patient. However, in group 2 (negative 
bacteremia), fimA detection in two samples in the 
same patient shows that two allelic variants of P. 
gingivalis. This result is in agreement with those 
previously reported by Eick et al. in a German 
population (28) and Enersen et al. (30).
The presence of unclassifiable strains that has 
been reported in Brazilian (25), Caucasian (31) 
and Japanese population (22) suggested that 
other fimA types associated with periodontitis 
disease flora may be present in the group under 
investigation. In order to validate this hypothesis, 
the entire fimA gene of the seven strains was 
sequenced. However, the fimA nucleotide 
sequences obtained showed high homology with 
nucleotide sequence of the references strains. 
Therefore, no new fimA types were evidenced. 
Nevertheless, fimA gene sequences of isolates 
were not in accordance with the specific fimA 
type combinations amplifications, supporting 
previous findings by Ernersen et al. (30).
One unique datum from the current study was 
discovered in contrast to previous studies (8,22-
24). When assessing fimA type I, some strains 
(12/30) showed a single amplicon (300 bp) not 
in accordance with the described 392 bp length 
Table 4. Distribution of fimA genotypes of 30 strains from 15 
patients and its relation with periodontal diagnostic.
                         Frequency of fimA type among
fimA type 30 strains patients with  
  periodontal
   diagnostic n= 15
 GCPn=9  GAPn=6
I 2/30 0/9 1/6  
Ib 5/30 3/9 0/6
II 16/30 3/9 5/6
III  3/30 2/9 0/6
IV 4/30 2/9 0/6
V 0/30 0/9 0/6
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product. A bioinformatic analysis of designated 
primers revealed that the fimA type IV reverse 
primer annealed with an intergenic region, as 
shown in the sequenced P. gingivalis genome 
of strain W83 [type IV fimA reference strain (32) 
GenBank accession number AE015924]. This 
information was confirmed with the recent whole 
genome sequence of P. gingivalis ATCC 33277 
(33). Considering that reverse primer annealing 
was common for fimA type IV, III, II and I, these 
cases were assumed to be annealing with an 
intergenic region. Therefore, the presence of 
the 300 bp product suggested that the type I 
fimA primers set can hybridize elsewhere in the 
genome of clinical strains.
In sum, fimA type II was assumed to be the 
most frequently detected type in Colombian 
periodontitis patients, and specifically in patients 
exhibiting GAP. Although fimA type II is the most 
frequent type of P. gingivalis isolated from the 
bloodstream (3/7), due to the heterogeneity 
of those strains, the frequency of any fimA 
type cannot be correlated with the ability of P. 
gingivalis strains to reach the bloodstream. The 
number of P. gingivalis strains per person in the 
Colombian periodontitis group is mostly restricted 
to one type. The P. gingivalis strain seems to be 
conserved within a period of one to four weeks, 
as revealed by genotyping data obtained from 
inclusion sampling and treatment sampling. 
In addition, the P. gingivalis strain found in the 
subgingival plaque sample was often correlated 
to P. gingivalis found in bloodstream.
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